Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifs. 2011

Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
Chroma Therapeutics Ltd, Abingdon, Oxon OX14 4RY, United Kingdom.

The therapeutic and toxic effects of drugs are often generated through effects on distinct cell types in the body. Selective delivery of drugs to specific cells or cell lineages would, therefore, have major advantages, in particular, the potential to significantly improve the therapeutic window of an agent. Cells of the monocyte-macrophage lineage represent an important target for many therapeutic agents because of their central involvement in a wide range of diseases including inflammation, cancer, atherosclerosis, and diabetes. We have developed a versatile chemistry platform that is designed to enhance the potency and delivery of small-molecule drugs to intracellular molecular targets. One facet of the technology involves the selective delivery of drugs to cells of the monocyte-macrophage lineage, using the intracellular carboxylesterase, human carboxylesterase-1 (hCE-1), which is expressed predominantly in these cells. Here, we demonstrate selective delivery of many types of intracellularly targeted small molecules to monocytes and macrophages by attaching a small esterase-sensitive chemical motif (ESM) that is selectively hydrolyzed within these cells to a charged, pharmacologically active drug. ESM versions of histone deacetylase (HDAC) inhibitors, for example, are extremely potent anticytokine and antiarthritic agents with a wider therapeutic window than conventional HDAC inhibitors. In human blood, effects on monocytes (hCE-1-positive) are seen at concentrations 1000-fold lower than those that affect other cell types (hCE-1-negative). Chemical conjugates of this type, by limiting effects on other cells, could find widespread applicability in the treatment of human diseases where monocyte-macrophages play a key role in disease pathology.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004950 Esterases Any member of the class of enzymes that catalyze the cleavage of an ester bond and result in the addition of water to the resulting molecules. Esterase
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino

Related Publications

Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
January 2018, International journal of nanomedicine,
Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
January 2020, Frontiers in pharmacology,
Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
January 2011, Journal of drug delivery,
Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
February 2012, Journal of controlled release : official journal of the Controlled Release Society,
Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
September 2014, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...,
Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
May 2010, Seminars in nephrology,
Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
June 2022, Pharmacology & therapeutics,
Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
January 2020, Advanced drug delivery reviews,
Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
June 2014, Hypertension (Dallas, Tex. : 1979),
Lindsey A Needham, and Alan H Davidson, and Lindsay J Bawden, and Andrew Belfield, and Elisabeth A Bone, and Deborah H Brotherton, and Sam Bryant, and Michael H Charlton, and Vanessa L Clark, and Stephen J Davies, and Alastair Donald, and Francesca A Day, and David Krige, and Valérie Legris, and Joanne McDermott, and Yvonne McGovern, and Jo Owen, and Sanjay R Patel, and Stéphane Pintat, and Richard J Testar, and Graham M A Wells, and David Moffat, and Alan H Drummond
April 2013, Rheumatology (Oxford, England),
Copied contents to your clipboard!